G-Eye Advanced Colonoscopy For Increased Polyp Detection Rate-randomized Tandem Study With Different Endoscopist
Launched by SMART MEDICAL SYSTEMS LTD. · Feb 16, 2014
Trial Information
Current as of July 04, 2025
Completed
Keywords
ClinConnect Summary
Single Center, two-arm, randomized , open-label study with different and blinded endoscopists.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Patients over 50 years old
- • 2. Referred to colonoscopy for screening, following positive FOBT testing, change of bowel habits or for surveillance colonoscopy (history of adenoma resection).
- • 3. The patient must understand and provide written consent for the procedure.
- Exclusion Criteria:
- • 1. Subjects with inflammatory bowel disease;
- • 2. Subjects with a personal history of polyposis syndrome;
- • 3. Subjects with suspected chronic stricture potentially precluding complete colonoscopy;
- • 4. Subjects with diverticulitis or toxic megacolon;
- • 5. Subjects with a history of radiation therapy to abdomen or pelvis;
- • 6. Pregnant or lactating female subjects;
- • 7. Subjects who are currently enrolled in another clinical investigation.
- • 8. Subjects with current oral or parenteral use of anticoagulants
- • 9. Subjects with recent (within the last 3 mounts) coronary ischemia or CVA (stroke)
About Smart Medical Systems Ltd.
Smart Medical Systems Ltd. is an innovative healthcare technology company dedicated to enhancing diagnostic and therapeutic procedures through advanced medical devices and software solutions. With a focus on improving patient outcomes and streamlining clinical workflows, the company leverages cutting-edge technology to develop tools that assist healthcare professionals in making informed decisions. Committed to rigorous clinical research and compliance with regulatory standards, Smart Medical Systems Ltd. aims to revolutionize the medical landscape by providing reliable, user-friendly solutions that address critical needs in various medical fields.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Frankfurt, , Germany
Patients applied
Trial Officials
Ralf Kiesslich, Prof.
Principal Investigator
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials